Skip to main content
Clinical Trials/NCT01747824
NCT01747824
Completed
Not Applicable

Stress Biomarkers Among Patients Undergoing Treatment for Excited Delirium and Severe Pain in the Emergency Department

Hennepin Healthcare Research Institute1 site in 1 country1,322 target enrollmentDecember 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Agitation
Sponsor
Hennepin Healthcare Research Institute
Enrollment
1322
Locations
1
Primary Endpoint
Change in Altered Mental Status Score
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The purpose of this project is to determine the levels of stress biomarkers associated with severe pain, agitation from intoxication or psychosis, and excited delirium at various levels of the disease in order to compare them to pre-clinical models of law enforcement encounters. We hypothesize that the serum catecholamines and markers of metabolic acidosis will worsen with the duration and severity of agitation among agitated patients and will not worsen among patients with severe pain who are not agitated.

Specific Aims

  • To assess the prevalence of patients undergoing treatment for agitation from any cause requiring restraint or sedation.
  • To assess the prevalence of excited delirium in the emergency department.
  • To determine the difference in serum total catecholamines, serum dopamine, serum epinephrine, serum norepinephrine, heart rate, systolic blood pressure, mean arterial pressure, mortality, and disposition among patients with agitation requiring restraint, including excited delirium and patients with severe pain from extremity fractures.
  • To describe changes in stress biomarkers among patients with changing levels of agitation as determined by the Altered Mental Status scale.

Detailed Description

In this study, we propose to study Emergency Department patients under physiologic stress from severe pain, agitation, drug overdose, and excited delirium in order to compare markers of acidosis in patients at risk for unexplained-in-custody-death (UICD) in order to determine the relationship of these markers to what has been found in simulated law enforcement encounters. This information will help clarify the levels of stress associated with arrest and restraint conditions, allowing us to determine what aspects and levels of stress may be associated with the fatal mechanisms of UICD, and to identify markers that would inform death investigators of the mechanism of UICD. At the conclusion of this project, we will be able to report details explaining the relationship of the physiologic and metabolic effects of stress from restraint in excited delirium to other peri-arrest conditions and our previous work in simulated law enforcement encounters.

Registry
clinicaltrials.gov
Start Date
December 2012
End Date
December 2015
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients with agitation as defined by an Altered Mental Status Score of \>1, and who are in restraints or are given sedatives for treatment of agitation.
  • Agitation Group

Exclusion Criteria

  • Less than 18 years of age
  • Suspected or confirmed pregnancy
  • Pain Group Inclusion Criteria:
  • Patients with an extremity fracture who report their pain as severe.
  • Pain Group Exclusion Criteria:
  • Less than 18 years of age
  • Suspected or confirmed pregnancy

Outcomes

Primary Outcomes

Change in Altered Mental Status Score

Time Frame: Assessed every five minutes, from enrollment until discharge from the emergency department, an expected average time of 4 hours

Change in Visual Analog Scale Pain Score

Time Frame: Assessed every five minutes, from enrollment until discharge from the emergency department, an expected average time of 4 hours

Change in Serum Total Catecholamines

Time Frame: Assessed every 30 minutes, from enrollment until discharge from the emergency department, an expected average time of 4 hours

Serum dopamine, serum epinephrine, and serum norepinephrine.

Secondary Outcomes

  • Length of Hospital Stay(Assessed at time of discharge from the hospital, an expected average of 4 hours post enrollment.)
  • Mortality(Observed for 1 year post study enrollment)
  • Complications(Observed for 1 year post study enrollment)
  • Change in Heart Rate(Observed from time of enrollment until discharge from the emergency department, an expected average time of 4 hours)
  • Change in Systolic Blood Pressure(Observed from time of enrollment until discharge from the emergency department, an expected average time of 4 hours)
  • Disposition(Assessed at discharge from the emergency department, an expected average of 4 hours post enrollment.)
  • Change in Mean Arterial Pressure(Observed from time of enrollment until discharge from the emergency department, an expected average time of 4 hours)
  • Change in Body Temperature(Observed from time of enrollment until discharge from the emergency department, an expected average time of 4 hours)
  • Change in end tidal carbon dioxide(Assessed from time of enrollment until discharge from the emergency department, an expected average time of 4 hours)
  • Change in Oxygen Saturation(Observed from time of enrollment until discharge from the emergency department, an expected average time of 4 hours)

Study Sites (1)

Loading locations...

Similar Trials